Rasad 1.5mg (Rasburicase Vials) 1.5mg

Rasad 1.5mg contains rasburicase, an enzyme therapy used to manage uric acid levels. This 1.5mg vial formulation is stored between 2-8°C and supports treatment protocols for elevated uric acid. Ideal for clinical settings requiring rapid urate reduction.

Strength

1.5mg

Pack Size

Storage

2-8°

Manufacturer / TM Owner

Sadaya Healthcare

Select Quantity

Pack/s

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

First Name

Last Name

Phone

Delivery Country

Delivery PostCode/Zipcode

Select Your Profile

I have read and agree to the terms & conditions, including the privacy policy, return policy, and usage terms as applicable to this request.

Indications & Clinical Uses

Rasad 1.5mg is used to lower high uric acid levels in the blood, often seen during cancer treatments like chemotherapy. It helps prevent complications such as tumor lysis syndrome by breaking down uric acid. This medication is typically administered under medical supervision to ensure proper monitoring.

Side Effects

Rasad 1.5mg works by converting uric acid into a more soluble form, which the body can more easily eliminate. Patients may notice improved kidney function as uric acid levels decrease. The process is gradual and requires consistent monitoring to assess effectiveness.

Precautions & Warnings

Store Rasad 1.5mg vials refrigerated between 2-8°C and protect from light. Avoid freezing or shaking the vial to maintain potency. Always check the solution for particles or discoloration before use. Discard any unused portion as directed by healthcare guidelines.

Avoid Interactions

Rasad 1.5mg may interact with medications that affect uric acid metabolism, such as allopurinol. Concurrent use with other urate-lowering therapies should be evaluated by a healthcare provider. Alcohol and certain supplements may also influence treatment outcomes.

Frequently Asked Questions

Rasad 1.5mg is used to reduce high uric acid levels, often during cancer treatments to prevent complications like tumor lysis syndrome.

Store Rasad 1.5mg vials refrigerated between 2-8°C and protect from light. Do not freeze or shake the vial.

Rasad 1.5mg is typically administered in a clinical setting under medical supervision due to the need for monitoring.

Common effects may include headache, nausea, or allergic reactions. Always report any unusual symptoms to a healthcare provider.

Consult a healthcare provider for personalized advice regarding Rasad 1.5mg use during pregnancy or breastfeeding.

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical supplier

Last updated: 29 Jul 2026

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.